Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 1, 2011, Pages 99-103

  Vasilkova, Olga ^a,b   Mokhort, Tatiana ^c   Sanec, Igor ^b   Sharshakova, Tamara ^a   Hayashida, Naomi ^d   Takamura, Noboru ^d  

^a GOMEL STATE MEDICAL UNIVERSITY   (Belarus)

^b Republican Research Center for Radiation Medicine and Human Ecology   (Belarus)

^c BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

Bone mineral density; Free testosterone; Men; Total testosterone; Type 2 diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; ESTRADIOL; FOLLITROPIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOREACTIVE INSULIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; ORAL ANTIDIABETIC AGENT; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BELARUS; BODY MASS; BONE DENSITOMETRY; BONE DENSITY; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; DUAL ENERGY X RAY DENSITOMETRY; ESTRADIOL BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LUMBAR SPINE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

BONE DENSITY; DIABETES MELLITUS, TYPE 2; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 79953145569     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.016     Document Type: Article

References (35)

1. Barrett-Connor E, Holbrook TL. Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. J Am Med Assoc 1992;268:3333-7.
2. Gregorio F, Cristallini S, Santeusanio F, Filipponi P, Fumelli P. Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diabetes Res Clin Pract 1994;23:43-54. (Pubitemid 24118514)
3. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999;353:878-82. (Pubitemid 29126875)
4. Jiang HX, Majumdar SR, Dick DA, Moreau M, Raso J, Otto DD, et al. Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fracture. J Bone Miner Res 2005;20:494-500. (Pubitemid 40297910)
5. Jackson SA, Tenenhouse A, Robertson L. Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 2000;11:680-7.
6. Osnes EK, Lofthus CM, Meyer HE, Falch JA, Nordsletten L, Cappelen I, et al. Consequences of hip fracture on activities of daily life and residential needs. Osteoporos Int 2004;15:567-74. (Pubitemid 38899919)
7. Fukui M, Soh J, Tanaka M, Kitagawa Y, Hasegawa G, Yoshikawa T, et al. Low serum testosterone concentration in middle-aged men with type 2 diabetes. Endocr J 2007;54:871-7. (Pubitemid 351346769)
8. LeBlanc ES, Nielson CM, Marshall LM, Lapidus JA, Barrett-Connor E, Ensrud KE, et al. The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men: Osteoporotic Fractures in Men Study Group. J Clin Endocrinol Metab 2009;94:3337-46.
9. Lipscombe LL, Jamal SA, Booth GL, Hawker GA. The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care 2007;30:835-41. (Pubitemid 46556575)
10. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
11. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72. (Pubitemid 30645223)
12. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C. Androgens and bone. Endocr Rev 2004;25:389-425. (Pubitemid 38786452)
13. Abu EO, Horner A, Kusec V, Triffitt JT, Compston JE. The localization of androgen receptors in human bone. J Clin Endocrinol Metab 1997;82:3493-7. (Pubitemid 27419110)
14. Noble B, Routledge J, Stevens H, Hughes I, Jacobson W. Androgen receptors in bone-forming tissue. Horm Res 1999;51:31-6. (Pubitemid 29154928)
15. Benz DJ, Haussler MR, Thomas MA, Speelman B, Komm BS. High-affinity androgen binding and androgenic regulation of α1(I)-procollagen and transforming growth factor-steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology 1991;128:2723-30.
16. Wiren K, Keenan E, Zhang X, Ramsey B, Orwoll E. Homologous androgen receptor up-regulation in osteoblastic cells may be associated with enhanced functional androgen responsiveness. Endocrinology 1999;140:3114-24. (Pubitemid 30650626)
17. Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, et al. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest 1995;95:2886-95.
18. Fukayama S, Tashjian AH. Direct modulation by androgens of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTHrp. Endocrinology 1989;125:1789-94. (Pubitemid 19258611)
19. Huber DM, Bendixen AC, Pathrose P, Srivastava S, Dienger KM, Shevde NK, et al. Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor. Endocrinology 2001;142:3800-8. (Pubitemid 32802650)
20. Vittek J, Altman K, Gordon GG, Southren AL. The metabolism of 7a-3H-testosterone by rat mandibular bone. Endocrinology 1974;94:325-9.
21. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 2000;106:1553-60. (Pubitemid 32038592)
22. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000;21:115-37. (Pubitemid 32275592)
23. Schubert M, Bullmann C, Minnemann T, Reiners C, Krone W, Jockenhovel F. Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism. Horm Res 2003;60:21-8. (Pubitemid 36693882)
24. Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston CC. Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. J Clin Invest 1997;100:1755-9. (Pubitemid 27431332)
25. Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F, Duboeuf F, et al. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab 2001;86:192-9. (Pubitemid 32109796)
26. van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 2001;85:3276-82.
27. Bjornerem A, Emaus N, Berntsen GK, Joakimsen RM, Fonnebo V, Wilsgaard T, et al. Circulating sex steroids, sex hormone-binding globulin, and longitudinal changes in forearm bone mineral density in postmenopausal women and men: the Tromso study. Calcif Tissue Int 2007;81:65-72. (Pubitemid 47228728)
28. Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem 1999;27:532-41.
29. Kayath MJ, Dib SA, Vieiaa JG. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J Diabetes Complications 1994;97:97-104. (Pubitemid 24375618)
30. Tanko LB, Bagger YZ, Nielsen SB, Christiansen C. Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? Bone 2003;32:8-14. (Pubitemid 36173807)
31. Rajendran KG, Chen SY, Sood A, Spielvogel BF, Hall IH. The antiosteoporotic activity of amine-carboxyboranes in rodents. Biomed Pharmacother 1995;49:131-40.
32. Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, et al. Atherogenic diet and minimally oxidized low density lipoproteins inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 1999;14:2067-78. (Pubitemid 30026956)
33. Blair HC, Athansou NA. Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol 2004;19:189-99. (Pubitemid 38111263)
34. Kha HT, Basseri B, Shouhed D, Richardson J, Tetradis S, Hahn TJ, et al. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat. J Bone Miner Res 2004;19:830-40. (Pubitemid 41094395)
35. Moris M, Peretz A, Tjeka R, Negaban N, Wouters M, Bergmann P. Quantitative ultrasound bone measurements: normal values and comparison with bone mineral density by dual X-ray absorptiometry. Calcif Tissue Int 1995;57:6-10.